160 HEALTH (02656) surged over 6%, reaching a record high of HK$52.8, marking a 343% increase from its IPO price of HK$11.89. At the time of writing, the stock was up 6.14% at HK$52.75, with a turnover of HK$31.55 million.

The company listed on September 17 this year. According to its prospectus, 160 HEALTH is an experienced Chinese pharmaceutical and healthcare product wholesaler and a leading integrated digital healthcare service provider. It offers a wide range of medical and health products, as well as comprehensive digital healthcare solutions.

As of March 31, 2025, the platform has connected over 44,600 healthcare institutions since its inception, including more than 14,400 hospitals (of which 3,430 are tertiary hospitals) and over 30,200 primary healthcare facilities.